福建海西新药创制股份有限公司向港交所提交上市申请

Group 1 - Fujian Haixi New Drug Creation Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange [1] - The joint sponsors for the listing are Huatai International and CMB International [1]